Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Efficacy and safety of fasiglifam (TAK‐875), a G protein‐coupled receptor 40 agonist, in J apanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double‐blind, placebo‐controlled, phase III trial
Intravenous dexamethasone‐cyclophosphamide pulse therapy in comparison with oral methylprednisolone‐azathioprine therapy in patients with pemphigus: Results of a multicenter prospectively randomized study: Intravenöse Dexamethason‐Cyclophosphamid‐Pulstherapie im Vergleich zu einer oralen Methylprednisolon‐Azathioprin‐Therapie bei Patienten mit Pemphigus‐Erkrankungen: Ergebnisse einer multizentrischen, prospektiven, randomisierten Studie
Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials